Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Natural Progesterone for the Treatment of Recurrent Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study of natural progesterone for recurrent glioblastoma and gliosarcoma is being conducted by Emory University, with status listed as active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: Emory University | Conditions: Gliosarcoma, Recurrent Glioblastoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING